
Sign up to save your podcasts
Or
We have newly appointed NBDF CEO, Phil Gattone with us sharing his background and his vision for the organization and community. And, we have the story of the first commercially dosed patient of hemophilia B gene therapy. Hear from Jamison Buxton, the father of the patient…who also happens to be the director of the HTC.
Show Notes:
Subscribe:
The BloodStream Podcast
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It’s a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
BloodStreamMedia.com
BloodStream on Facebook
BloodStream on Twitter
4.9
4242 ratings
We have newly appointed NBDF CEO, Phil Gattone with us sharing his background and his vision for the organization and community. And, we have the story of the first commercially dosed patient of hemophilia B gene therapy. Hear from Jamison Buxton, the father of the patient…who also happens to be the director of the HTC.
Show Notes:
Subscribe:
The BloodStream Podcast
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It’s a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media:
BloodStreamMedia.com
BloodStream on Facebook
BloodStream on Twitter
10,406 Listeners
43,483 Listeners
12,103 Listeners
14,547 Listeners
86,708 Listeners
111,917 Listeners
14 Listeners
24 Listeners
56,231 Listeners
14,843 Listeners
5,942 Listeners
14,397 Listeners
42 Listeners
6 Listeners
6,066 Listeners
57,990 Listeners
9 Listeners
15 Listeners
2 Listeners
10 Listeners
10 Listeners
12 Listeners
1,169 Listeners
1,668 Listeners
7,419 Listeners